KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Non-Current Deffered Revenue (2020 - 2025)

Ginkgo Bioworks Holdings filings provide 6 years of Non-Current Deffered Revenue readings, the most recent being $75.2 million for Q4 2025.

  • On a quarterly basis, Non-Current Deffered Revenue fell 23.89% to $75.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $75.2 million, a 23.89% decrease, with the full-year FY2025 number at $75.2 million, down 23.89% from a year prior.
  • Non-Current Deffered Revenue hit $75.2 million in Q4 2025 for Ginkgo Bioworks Holdings, up from $74.1 million in the prior quarter.
  • In the past five years, Non-Current Deffered Revenue ranged from a high of $179.9 million in Q2 2023 to a low of $18.7 million in Q4 2021.
  • Median Non-Current Deffered Revenue over the past 5 years was $89.6 million (2024), compared with a mean of $102.4 million.
  • The widest YoY moves for Non-Current Deffered Revenue: up 832.29% in 2022, down 87.12% in 2022.
  • Ginkgo Bioworks Holdings' Non-Current Deffered Revenue stood at $18.7 million in 2021, then skyrocketed by 832.29% to $174.8 million in 2022, then decreased by 9.56% to $158.1 million in 2023, then crashed by 37.5% to $98.8 million in 2024, then dropped by 23.89% to $75.2 million in 2025.
  • The last three reported values for Non-Current Deffered Revenue were $75.2 million (Q4 2025), $74.1 million (Q3 2025), and $74.6 million (Q2 2025) per Business Quant data.